fda guidance on co-development of therapeutics and companion diagnostics
Published 10 years ago • 216 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
55:02
planning for co-development of companion diagnostics
-
1:07:27
webinar: principles for co-development of in-vitro companion diagnostic device w therapeutic product
-
0:48
key considerations for co-developing therapeutics and companion diagnostics
-
36:41
panel discussion: co-development of drugs and companion diagnostics
-
1:01:41
companion diagnostics webinar recording
-
13:21
overview of the fda product-specific guidance program
-
7:57
complying with fda guidance documents
-
15:35
what is a de novo?
-
1:36:15
software validation documentation for fda 510(k) pre-market notification submission
-
48:41
computer software assurance (csa): understanding the fda’s new draft guidance
-
0:58
cdx or companion diagnostics
-
22:48
11/10/2014 - session 2a - overview of fda regulations for diagnostics
-
1:45
companion diagnostics in cancer
-
44:10
fda guidances in 2020: a high-level pharma, device and diagnostic overview
-
6:32
companion diagnostics
-
4:01
strategies for companion diagnostic development
-
50:58
keynote presentation: a regulatory perspective on molecular diagnostic devices
-
57:12
drug, diagnostic and device development: from scientific findings to fda approval
-
16:57
companion diagnostics with andrew crenshaw
-
8:29
fda approves first companion diagnostic for her2 low metastatic breast cancer
-
7:45
fda guidance for interoperable devices
-
41:15
understanding the new fda guidance on data standards